Clinical Trials Directory

Trials / Completed

CompletedNCT00694148

Safety and Efficacy of NT 201, Free of Complexing Proteins, in the Treatment of Glabellar Frown Lines

NT 201 is a Botulinum Toxin Type A Preparation Free of Complexing Proteins. Injected Into the Muscle, NT 201 Causes a Reversible Local Relaxation of the Injected Muscle. Botulinum Toxin Type A is Widely Used for Aesthetic Treatment of Mimic Wrinkles. This Study Will Investigate the Safety and Efficacy of NT 201 in the Treatment of Glabellar Frown Lines.

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
108 (actual)
Sponsor
Merz Pharmaceuticals GmbH · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

NT 201 is a Botulinum toxin type A preparation free of complexing proteins. Injected into the muscle, NT 201 causes a reversible local relaxation of the injected muscle. Botulinum toxin type A is widely used for aesthetic treatment of mimic wrinkles. This study will investigate the safety and efficacy of NT 201 in the treatment of glabellar frown lines.

Conditions

Interventions

TypeNameDescription
DRUGNT 201A Botulinum neurotoxin type A, free of complexing proteins Detailed described in study protocol

Timeline

Start date
2008-05-01
Primary completion
2009-01-01
Completion
2009-01-01
First posted
2008-06-10
Last updated
2012-10-30

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00694148. Inclusion in this directory is not an endorsement.